|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001779,
umls-concept:C0012634,
umls-concept:C0025266,
umls-concept:C0033204,
umls-concept:C0138741,
umls-concept:C0220908,
umls-concept:C0439092,
umls-concept:C0439275,
umls-concept:C0449450,
umls-concept:C0681842,
umls-concept:C1366489,
umls-concept:C1417779
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-7-2
|
|
pubmed:abstractText |
To examine age and pretreatment prostate-specific antigen (PSA) level as predictors of organ-confined disease in a large multinational database of men with pretreatment PSA levels less than 10 ng/mL who were treated with radical prostatectomy. The optimal PSA and age cutoffs for triggering prostate biopsy are controversial. Although a PSA level greater than 4.0 ng/mL is generally accepted, recent observations suggest that PSA values between 2.5 and 4.0 ng/mL are associated with a 20% detection rate. Furthermore, age has been shown to represent an independent predictor of outcome after radical prostatectomy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1527-9995
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
62
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
70-4
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12837425-Adenocarcinoma,
pubmed-meshheading:12837425-Adult,
pubmed-meshheading:12837425-Age Factors,
pubmed-meshheading:12837425-Aged,
pubmed-meshheading:12837425-Biological Markers,
pubmed-meshheading:12837425-Biopsy,
pubmed-meshheading:12837425-Cohort Studies,
pubmed-meshheading:12837425-Databases, Factual,
pubmed-meshheading:12837425-Disease-Free Survival,
pubmed-meshheading:12837425-Humans,
pubmed-meshheading:12837425-Male,
pubmed-meshheading:12837425-Mass Screening,
pubmed-meshheading:12837425-Middle Aged,
pubmed-meshheading:12837425-Multivariate Analysis,
pubmed-meshheading:12837425-Neoplasm Invasiveness,
pubmed-meshheading:12837425-Neoplasm Staging,
pubmed-meshheading:12837425-Predictive Value of Tests,
pubmed-meshheading:12837425-Prostate-Specific Antigen,
pubmed-meshheading:12837425-Prostatectomy,
pubmed-meshheading:12837425-Prostatic Neoplasms,
pubmed-meshheading:12837425-Tumor Markers, Biological
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening.
|
|
pubmed:affiliation |
Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|
